{"id":25404,"date":"2025-07-09T09:00:29","date_gmt":"2025-07-09T13:00:29","guid":{"rendered":"https:\/\/www.emilysentourage.org\/?p=25404"},"modified":"2025-07-09T08:47:42","modified_gmt":"2025-07-09T12:47:42","slug":"new-emilys-entourage-research-grant-to-advance-phage-therapy-for-drug-resistant-cystic-fibrosis-infections","status":"publish","type":"post","link":"https:\/\/www.emilysentourage.org\/sv\/new-emilys-entourage-research-grant-to-advance-phage-therapy-for-drug-resistant-cystic-fibrosis-infections\/","title":{"rendered":"Forskningsanslag fr\u00e5n New Emily's Entourage f\u00f6r att utveckla fagterapi mot l\u00e4kemedelsresistenta infektioner vid cystisk fibros"},"content":{"rendered":"<p style=\"text-align: center;\"><i><span style=\"font-weight: 400;\">Ett nyfinansierat projekt vid San Diego State University syftar till att optimera nya bakteriofag-antibiotiska behandlingar f\u00f6r sv\u00e5rbehandlade CF-patogener, som driver sjukdomsutvecklingen hos personer med CF.\u00a0<\/span><\/i><\/p>\n<div id=\"attachment_25408\" style=\"width: 450px\" class=\"wp-caption alignright\"><img fetchpriority=\"high\" decoding=\"async\" aria-describedby=\"caption-attachment-25408\" class=\"wp-image-25408 size-portrait\" src=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Anca_IMG_4254small-440x550.jpg\" alt=\"\" width=\"440\" height=\"550\" srcset=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Anca_IMG_4254small-440x550.jpg 440w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Anca_IMG_4254small-9x12.jpg 9w\" sizes=\"(max-width: 440px) 100vw, 440px\" \/><p id=\"caption-attachment-25408\" class=\"wp-caption-text\">Anca Segalls banbrytande arbete handlar om att optimera fagterapi f\u00f6r multiresistenta Achromobacter-infektioner - en av de farligaste och mest outforskade patogenerna vid CF.<\/p><\/div>\n<p><b>Lower Merion, PA-9 juli 2025<\/b><span style=\"font-weight: 400;\">-Emily's Entourage (EE), en innovativ 501(c)(3)-organisation som p\u00e5skyndar forskning f\u00f6r personer med cystisk fibros (CF) som inte kan dra nytta av befintliga CFTR-modulatorbehandlingar, har tillk\u00e4nnagivit ett nytt forskningsanslag f\u00f6r 2025 till Anca Segall, PhD, professor i biologi vid San Diego State University. Finansieringen st\u00f6der Dr. Segalls banbrytande arbete med att optimera fagterapi f\u00f6r multiresistenta <\/span><i><span style=\"font-weight: 400;\">Achromobacter<\/span><\/i><span style=\"font-weight: 400;\"> infektioner - en av de farligaste och mest outforskade patogenerna vid CF.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Fagterapi (PT), som anv\u00e4nder bakterievirus, s\u00e5 kallade bakteriofager, f\u00f6r att angripa skadliga bakterier, blir allt vanligare som en sista utv\u00e4g f\u00f6r att behandla antibiotikaresistenta infektioner. Genom detta nya EE-finansierade projekt, med titeln \"Optimizing Phage Cocktails for Therapy Targeting <\/span><i><span style=\"font-weight: 400;\">Achromobacter<\/span><\/i><span style=\"font-weight: 400;\">Dr Segalls team kommer att arbeta med att identifiera de b\u00e4sta kombinationerna av fager och antibiotika f\u00f6r att bek\u00e4mpa <\/span><i><span style=\"font-weight: 400;\">Achromobacter<\/span><\/i><span style=\"font-weight: 400;\">en patogen som \u00e4r resistent mot de flesta antibiotika och som \u00e4r kopplad till f\u00f6rs\u00e4mrad h\u00e4lsa hos personer med CF.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Genom att kartl\u00e4gga hur bakterier utvecklar resistens mot fager - och hur dessa resistensf\u00f6r\u00e4ndringar p\u00e5verkar antibiotikak\u00e4nsligheten - f\u00f6rs\u00f6ker projektet utveckla smartare och effektivare behandlingar som inte bara d\u00f6dar bakterierna, utan potentiellt \u00e5ter g\u00f6r dem k\u00e4nsliga f\u00f6r antibiotika och minskar deras kondition \u00f6ver tid.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\"Trots de anm\u00e4rkningsv\u00e4rda effekterna av de CFTR-modulatorer som f\u00f6r n\u00e4rvarande finns tillg\u00e4ngliga, saknar n\u00e4stan 10% av CF-gruppen fortfarande fungerande behandlingsalternativ\", s\u00e4ger Dr Segall. \"Dessa individer \u00e4r s\u00e4rskilt s\u00e5rbara f\u00f6r d\u00f6dliga infektioner fr\u00e5n patogener som <\/span><i><span style=\"font-weight: 400;\">Achromobacter<\/span><\/i><span style=\"font-weight: 400;\">f\u00f6r vilken det i stort sett inte finns n\u00e5gra riktade forskningsprogram och f\u00e5 FDA-godk\u00e4nda behandlingar. Emily's Entourages st\u00f6d \u00e4r avg\u00f6rande f\u00f6r att vi ska kunna utveckla de verktyg vi s\u00e5 snabbt beh\u00f6ver f\u00f6r att behandla <\/span><i><span style=\"font-weight: 400;\">Achromobacter<\/span><\/i><span style=\"font-weight: 400;\"> i CF-populationen.\"<\/span><\/p>\n<p><span style=\"font-weight: 400;\">F\u00f6rutom att karakterisera hur specifika fager fungerar och hur <\/span><i><span style=\"font-weight: 400;\">Achromobacter<\/span><\/i><span style=\"font-weight: 400;\"> motst\u00e5r eller faller till f\u00f6ga f\u00f6r behandlingen kommer Dr Segalls team att anv\u00e4nda kliniska prover och metagenomiska data fr\u00e5n tidigare fall av fagterapi f\u00f6r att f\u00f6rb\u00e4ttra framtida behandlingsstrategier och identifiera synergier mellan kombinationer av fag och antibiotika. Projektets resultat kan ligga till grund f\u00f6r individanpassade precisionsbehandlingar och delas med CF-l\u00e4kare och forskare \u00f6ver hela v\u00e4rlden.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\"EE \u00e4r djupt engagerade i att finansiera den mest lovande forskningen med h\u00f6g genomslagskraft f\u00f6r att n\u00e5 de 10% personer med CF som fortfarande v\u00e4ntar p\u00e5 ett genombrott\", s\u00e4ger Chandra Ghose, PhD, Chief Scientific Officer p\u00e5 EE. \"Det h\u00e4r projektet exemplifierar v\u00e5rt uppdrag - att p\u00e5skynda dj\u00e4rv, innovativ forskning som \u00f6verbryggar kritiska luckor och g\u00f6r att livsf\u00f6r\u00e4ndrande terapier snabbt blir tillg\u00e4ngliga.\"<\/span><\/p>\n<p><b>Om Emily's Entourages (EE's) stipendieprogram\u00a0<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Emily's Entourage's (EE's) Grant Program ger anslag f\u00f6r att p\u00e5skynda forskning och terapeutisk utveckling f\u00f6r personer med cystisk fibros (CF) som inte har nytta av befintliga mutationsinriktade behandlingar. EE tillhandah\u00e5ller finansiering genom flera mekanismer f\u00f6r bidragsfinansiering, inklusive \u00f6vers\u00e4ttningsbidrag, samarbetsbidrag och prekliniska unders\u00f6kningsbidrag, samt genom riskfilantropiska investeringar.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Hittills har EE beviljat miljontals dollar till tv\u00e4rvetenskapliga team runt om i v\u00e4rlden och hj\u00e4lpt till att s\u00e4kra miljontals dollar i f\u00f6ljdfinansiering. F\u00f6r att se beviljade anslag, bes\u00f6k <\/span><a href=\"https:\/\/www.emilysentourage.org\/sv\/awarded-grants\/\"><span style=\"font-weight: 400;\">https:\/\/www.emilysentourage.org\/awarded-grants\/<\/span><\/a><span style=\"font-weight: 400;\">. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">F\u00f6r att l\u00e4ra dig mer om EE:s finansieringsm\u00f6jligheter, bes\u00f6k <\/span><a href=\"https:\/\/www.emilysentourage.org\/sv\/funding-opportunities\/\"><span style=\"font-weight: 400;\">https:\/\/www.emilysentourage.org\/funding-opportunities\/<\/span><\/a><span style=\"font-weight: 400;\">.\u00a0<\/span><\/p>\n<p><b>Om Emily's Entourage<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Emily's Entourage \u00e4r en innovativ 501(c)3 som p\u00e5skyndar forskning f\u00f6r nya behandlingar och ett botemedel f\u00f6r individer i den sista 10% av cystisk fibros (CF)-populationen som inte drar nytta av f\u00f6r n\u00e4rvarande tillg\u00e4ngliga mutationsinriktade terapier. Sedan 2011 har Emily's Entourage beviljat miljontals dollar i forskningsanslag, lanserat ett genterapibolag f\u00f6r CF som nu befinner sig i klinisk fas, utvecklat patientdatabasen Clinical Trial Connect (CTC) och ett matchningsprogram f\u00f6r kliniska pr\u00f6vningar f\u00f6r att p\u00e5skynda rekryteringen till kliniska pr\u00f6vningar samt lett globala insatser f\u00f6r att driva forskning och l\u00e4kemedelsutveckling med stor genomslagskraft. Organisationen har omn\u00e4mnts i nationella medier, bland annat New York Times, STAT, CNN, People med flera. L\u00e4s mer p\u00e5 <\/span><a href=\"https:\/\/www.emilysentourage.org\/sv\/\"><span style=\"font-weight: 400;\">emilysentourage.org<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><b>Kontakt med media<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Hannah Kleckner<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Direkt\u00f6r f\u00f6r marknadsf\u00f6ring och kommunikation<\/span><\/p>\n<p><span style=\"font-weight: 400;\">hannah@emilysentourage.org<\/span><\/p>\n<p><br style=\"font-weight: 400;\" \/><br style=\"font-weight: 400;\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>Newly-funded San Diego State University project aims to optimize novel bacteriophage-antibiotic treatments for hard-to-treat CF pathogens, which drive disease progression in individuals with CF.\u00a0 Lower Merion, PA\u2014July 9, 2025\u2014Emily\u2019s Entourage (EE), an innovative 501(c)(3) organization accelerating research for individuals with cystic fibrosis (CF) who do not benefit from existing CFTR modulator therapies, has announced a&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/www.emilysentourage.org\/sv\/new-emilys-entourage-research-grant-to-advance-phage-therapy-for-drug-resistant-cystic-fibrosis-infections\/\" class=\"excerpt-read-more\">L\u00e4s mer om<\/a><\/p>","protected":false},"author":1719,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_titles_title":"%%post_title%%","_seopress_titles_desc":"%%post_excerpt%%","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"none","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","_seopress_news_disabled":"","_seopress_video_disabled":"","_seopress_video":[],"_seopress_pro_schemas_manual":[],"_seopress_pro_rich_snippets_disable_all":"","_seopress_pro_rich_snippets_disable":[],"_seopress_pro_schemas":[],"_monsterinsights_skip_tracking":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[178],"tags":[197,208,216,91,189],"class_list":["post-25404","post","type-post","status-publish","format-standard","hentry","category-press-releases","tag-cf-research","tag-cystic-fibrosis-research","tag-ee-grants","tag-grants","tag-phage-therapy"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts\/25404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/users\/1719"}],"replies":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/comments?post=25404"}],"version-history":[{"count":5,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts\/25404\/revisions"}],"predecessor-version":[{"id":25412,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts\/25404\/revisions\/25412"}],"wp:attachment":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/media?parent=25404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/categories?post=25404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/tags?post=25404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}